跳至主要内容
临床试验/NCT05640323
NCT05640323已完成不适用

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Pulse Rate

Norbert Health2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2023年4月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
2
主要终点
Mean Average Error (MAE)

研究概览

简要总结

The study will evaluate the mean average error (MAE) of measuring pulse rate using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

详细描述

The study design is to validate the pulse and heart rate accuracy as required per ISO 80601-2-61, Clause 201.12.1.104. The study is a non-randomized, non-blinded single arm design to evaluate the clinical accuracy of the ND's pulse rate measurement compared to a reference heart rate manually measured by observing R-peaks in a standard concurrently recorded ECG from an FDA 510(k)-cleared reference clinical ECG (RCECG). The sponsor will ensure that the study staff enrolls a range of types of arrhythmias including tachycardia, bradycardia, atrial fibrillation, bigeminy, trigeminy, and others.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects aged 18 or over
  • Ability to provide signed informed consent

排除标准

  • Otherwise deemed unsuitable to participate in the study based on judgment of the study investigator

结局指标

主要结局

Mean Average Error (MAE)

时间窗: Up to 1 hour

MAE will be evaluated by Mean absolute error (MAE) of the pulse rate of the device compared to the heart rate measured from the RCECG.

次要结局

未报告次要终点

研究者

发起方
Norbert Health
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验